Context-dependent expansion of CH genotypes. Several lines of evidence suggest molecular abnormalities driving CH are acquired early in life. Detection of CH is rare for individuals aged <50 years. The ability to detect CH increases with age, corresponding to a decline in HSPC diversity. Male sex, inherited germ line predisposition, systemic inflammation, chemotherapy/radiation therapy exposure, and smoking each select for distinct CH genotypes.